Kathleen Derose serves as Executive at Enfusion, Inc., where they oversee executive responsibilities. Since joining the company, Kathleen Derose has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 13, 2024 involved receiving (via award) 13,470 shares valued at $0.
Kathleen Derose currently holds 60,716 shares of Enfusion, Inc. (ENFN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathleen Derose has been a net neutral trader of ENFN stock. They have purchased $0 and sold $0 worth of shares.
Kathleen Derose's most recent insider trade was on Jun 13, 2024, when they sold 13,470 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 27, 2022 | ENFN | $0 | Award | 2,791 | $N/A | Discretionary |
| Jun 15, 2022 | ENFN | $0 | Award | 12,678 | $N/A | Discretionary |
| Oct 31, 2021 | ENFN | $0 | Award | 11,029 | $N/A | Discretionary |
| Oct 31, 2021 | ENFN | $0 | Award | 5,515 | $N/A | Discretionary |